1Mir TS,Marohn S,Laer S,et al.Plasma concentration of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure[J].Pediatrics,2002,110:e76.
2Muta H,Ishii M,Maeno Y,et al.Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect[J].Acta paediatr,2002,91:649-652.
3Bhat G,Costea A.Reversibility of medically unresponsive pulmonary hypertention with nisiritide in a cardiac transplant recipient[J].ASAIO J,2003,49:608-610.
3De Wald TA, Hernandez AF. Efficacy and safety of nesirtide in patients with acute decompensated heart failure [J]. Expert Rev Cardiovasc Ther, 2010,8 (2) : 159-169.
4Rademaker MT,Charles CJ ,Melton IC ,et al. Monitoring of heart failure: comparison of left atrial pressure with intrathoracie impedance and na- triuretie peptide measurements in an experimental model of ovine heart failure [J]. Clin Sei(Lond) ,2011,120(5) :207-217.
7De Wald TA,Hernandez AF.Efficacy and safety of nesirtide in patients with acute decompensated heart failure[J].Expert Rev Cardiovasc Ther,2010,8(2):159-169.
8Rademaker MT,Charles CJ,Melton IC,et al.Monitoring of heart failure:Comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure[J].Clin Sci(Lond),2011,120(5):207-217.
9Gigante A,Liberatori M,Gasperini ML,et al.Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward[J].Cardiorenal Med,2014,4(2):88-94.
10Saitoh M,Itoh H,Morotomi N,et al.Impact of chronic kidney disease and anemia on physical function in patients with chronic heart failure[J].Cardiorenal Med,2014,4(2):73-81.
